Alcon
Europe, Geneve, Switzerland, Vernier
Description
Alcon specializes in developing and manufacturing innovative medicines and devices to serve the full life cycle of eye care needs.
Investor Profile
Alcon has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 67% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, China, Germany.
- Strong thematic focus on Biotechnology, Biopharma, Health Care.
- Led 1 rounds in the past year.
Stage Focus
- Series Unknown (67%)
- Post Ipo Equity (33%)
Country Focus
- United States (33%)
- China (33%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Germany (33%)
Industry Focus
- Biotechnology
- Biopharma
- Health Care
- Medical
- Pharmaceutical
- Therapeutics
- Computer Vision
- Image Recognition
- Manufacturing
- Psychology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
